Results for tag: "Integrin Alpha V"

Integrin Alpha V is a type of integrin, a family of proteins that play a role in cell adhesion and migration. In the context of oncology drugs, Integrin Alpha V is a target for the development of therapies to treat cancer. It is believed that blocking the activity of Integrin Alpha V can help to reduce the spread of cancer cells and the formation of new blood vessels that feed tumors. Integrin Alpha V is being studied in combination with other drugs to treat a variety of cancers, including breast, ovarian, and lung cancer. Several companies are developing drugs targeting Integrin Alpha V, including AstraZeneca, Merck, and Novartis. Additionally, several biotechnology companies are researching and developing Integrin Alpha V-targeting drugs, such as AbbVie, Amgen, and Gilead Sciences. Show Less Read more